LSTA Lisata Therapeutics - terminates merger agreement with kuva Labs on July 24, 2026 - SEC filing - Termination due to kuva Labs' failure

LSTA Lisata Therapeutics - terminates merger agreement with kuva Labs on July 24, 2026 - SEC filing - Termination due to kuva Labs' failure to obtain financing and accept tendered shares - SEC filing - Board to assess strategic options including reverse merger or asset sales - SEC filing